The epigenetics market is expected to reach USD 890.0 million by 2020 from USD 469.6 million in 2015, at a CAGR of 13.64% between 2015 and 2020. By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further subsegmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further subsegmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further subsegmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. The kits segment is expected to grow at the highest rate. Based on research areas, the market is segmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.
Market growth is majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global epigenetics market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
The report provides insights on the following:
- Product Development: Product portfolios of the top players in the epigenetics market.
- Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.